Takehiro Hiraoka

ORCID: 0009-0006-4030-3278 · 32 papers in corpus
observational 2026
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2026.105699

RESEARCH QUESTION: Does adenomyosis increase the risk of thromboembolic events, including both arterial and venous thromboembolism, compared with endometriosis, and what clinical factors may contribute to this association? DESIGN: This ret…

lab-animal 2026
Journal of the Endocrine Society ·doi:10.1210/jendso/bvag056

Adenomyosis is an intractable gynecological disorder that can give rise to severe pelvic pain, heavy menstrual bleeding, and infertility, predominantly affecting women of reproductive age. The limited efficacy of current pharmacological int…

review 2026
Reproductive medicine and biology ·doi:10.1002/rmb2.70042

BACKGROUND: Despite advances in assisted reproductive technology (ART), embryo implantation remains inefficient and represents a major barrier to successful pregnancy. Recurrent implantation failure persists even after transfer of high-qual…

other 2026
Reproductive medicine and biology ·doi:10.1002/rmb2.70028

PURPOSE: Recurrent implantation failure (RIF) is a form of refractory infertility that persists despite assisted reproductive technology. Cine magnetic resonance imaging (cine MRI) enables the visualization of uterine peristalsis; however, …

other 2025
Scientific reports ·doi:10.1038/s41598-025-92906-9

Chronic endometritis (CE) and endometrial dysbiosis (ED) are major causes of recurrent implantation failure (RIF). CE is diagnosed via hysteroscopy or the endometrial CD138 test; ED is examined using endometrial microbiome testing with next…

other 2025
BMC women's health ·doi:10.1186/s12905-025-03817-w

Adenomyosis often causes dysmenorrhea in women of reproductive age. Progestins such as levonorgestrel intrauterine system (LNG-IUS) are often used for treatment, but some patients experience progesterone resistance, showing poor treatment r…

review 2023
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15759

Recurrent implantation failure (RIF) remains a challenging problem in assisted reproductive technology (ART). Further insights into uterine abnormalities that can disturb embryo implantation should be obtained. This review provides an overv…

other 2023
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-022-01077-9

Levonorgestrel-releasing intrauterine system (LNG-IUS) relieves dysmenorrhea and heavy menstrual bleeding (HMB) in adenomyosis. However, its efficacy on health-related quality of life (HR-QOL) in patients with symptomatic adenomyosis remain…

observational 2023
BMC pregnancy and childbirth ·doi:10.1186/s12884-023-05956-0

BACKGROUND: Adenomyosis is a common gynecological disease in women of reproductive age and causes various symptoms such as dysmenorrhea and heavy menstrual bleeding. However, the influence of pregnancy on the progression of adenomyosis rema…

lab-animal 2023
Cell death & disease ·doi:10.1038/s41419-023-05832-x

Infertility occurs in 15% of couples worldwide. Recurrent implantation failure (RIF) is one of the major problems in in vitro fertilization and embryo transfer (IVF-ET) programs, and how to manage patients with RIF to achieve successful pre…

lab-animal 2022
Endocrinology ·doi:10.1210/endocr/bqac044

Adenomyosis is a benign uterine disease that causes dysmenorrhea, heavy menstrual bleeding, and infertility; however, its pathophysiology remains unclear. Since signal transducer and activator of transcription 3 (STAT3) is crucial for endom…

lab-animal 2022
Scientific reports ·doi:10.1038/s41598-022-22413-8

The purpose of this study was to establish a novel mouse model of adenomyosis suitable for longitudinal and quantitative analyses and perinatal outcome studies. Using a 30 G needle, the entire uterine wall of one horn was mechanically punct…

lab-animal 2022
·doi:10.21203/rs.3.rs-1332354/v2

Abstract Background: The purpose of this study was to establish a novel mouse model of adenomyosis suitable for longitudinal and quantitative analyses and perinatal outcome studies. Methods: Using a 30 G needle, the entire ute…

2022
·doi:10.21203/rs.3.rs-1332354/v1
2022
·doi:10.1016/j.xfnr.2022.11.004
observational 2022
Gynecology and Minimally Invasive Therapy ·doi:10.4103/gmit.gmit_9_22

For preparing the optimal condition in transcervical resection (TCR) surgery, gonadotropin-releasing hormone (GnRH) agonist has been utilized. Recently, an oral GnRH antagonist (relugolix) is available and acts directly on GnRH receptor, av…

lab-animal 2021
Scientific reports ·doi:10.1038/s41598-020-79578-3

In endometriosis, M2 MΦs are dominant in endometriotic lesions, but the actual role of M2 MΦ is unclear. CD206 positive (+) MΦ is classified in one of M2 type MΦs and are known to produce cytokines and chemokines. In the present study, we u…

2021
·doi:10.1016/b978-0-12-820661-4.00011-x
2021
·doi:10.1016/j.jri.2021.103391
other 2021
Biomedicines ·doi:10.3390/biomedicines9111519

Sphingosine 1-phosphate (S1P), an inflammatory mediator, is abundantly contained in red blood cells and platelets. We hypothesized that the S1P concentration in the peritoneal cavity would increase especially during the menstrual phase due …

lab-animal 2020
Scientific reports ·doi:10.1038/s41598-020-65884-3

The uterus plays an important and unique role during pregnancy and is a dynamic organ subjected to mechanical stimuli. It has been reported that infertility occurs when the peristalsis is prevented, although its mechanisms remain unknown. I…

2020
·doi:10.1016/j.jri.2020.103238
other 2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-019-00090-9

In endometriosis, M2 macrophages (MΦ) are dominant and promote the development of endometriosis lesions. However, the factor(s) which induces M2 MΦ are unknown. In the present study, we focused on interleukin (IL)-33, known as an alarmin an…

lab-animal 2020
Biomedicines ·doi:10.3390/biomedicines8110467

Relaxin (RLX)-2, produced by the corpus luteum and placenta, is known to be potentially effective in fibrotic diseases of the heart, lungs, kidneys, and bladder; however, its effectiveness in endometriosis has not yet been investigated. In …

2017